Primary Care and PCNs

Applied filters

Primary Care and PCNs

Care Setting (66)
- Adults (7)
- Care homes (10)
- Care of the elderly (1)
- Community Health Services (17)
- Dentistry (3)
- Health and Justice (14)
- Neonates (1)
- Occupational Health (3)
- Paediatrics (3)
- Palliative and End of Life Care (4)
- Primary Care and PCNs (66)
- Transfer of care (9)
- Trusts (17)
Events (16)
- Past Events (16)
Guidance (44)
- Adherence (1)
- Administering (8)
- Adverse effects (3)
- Cautions and contraindications (1)
- Complementary medicines (3)
- Dosing (1)
- Formulation (1)
- Implementation (2)
- Interactions (3)
- Medication Safety (3)
- Patient Group Directions (13)
- Poisoning (1)
- Policy, Commissioning and Managerial (3)
- Prescribing (2)
- Safety in Breastfeeding (1)
- Safety in Pregnancy (1)
- Service advice and planning (5)
- Supply (7)
- Swallowing difficulties (3)
- Switching (4)
- Temperature management (1)
  - Cold chain management (1)
- Unlicensed medicines (1)
Medicine (14)
- Adrenaline (2)
- Agomelatine (1)
- Alendronic acid (1)
- Amantadine (1)
- Amitriptyline (1)
- Amoxicillin (1)
- Articaine + Adrenaline (1)
- Atorvastatin (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Bromocriptine (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- COVID-19 vaccine (1)
- Cabergoline (1)
- Carbamazepine (2)
- Carbidopa + Levodopa + Entacapone (2)
- Cholesterol + Simvastatin (1)
- Ciclosporin (1)
- Citalopram (1)
- Clozapine (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Duloxetine (1)
- Entacapone (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvastatin (1)
- Fluvoxamine (1)
- Ibandronic acid (1)
- Imipramine (1)
- Influenza vaccine (1)
- Isocarboxazid (1)
- Levodopa (1)
- Levodopa + Carbidopa + Entacapone (2)
- Levothyroxine (1)
- Lidocaine (1)
- Lidocaine + Adrenaline (1)
- Lidocaine + Prilocaine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Lovastatin (1)
- Mepivacaine (1)
- Mepivacaine + Adrenaline (1)
- Mesalazine (1)
- Methotrexate (2)
- Methylphenidate (1)
- Mianserin (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nifedipine (1)
- Nortriptyline (1)
- Oseltamivir (1)
- Oxycodone (1)
- Paroxetine (1)
- Pergolide (1)
- Phenelzine (1)
- Phenobarbital (1)
- Phenoxymethylpenicillin (1)
- Phenytoin (2)
- Pramipexole (1)
- Pravastatin (1)
- Prilocaine (1)
- Prilocaine + Felypressin (1)
- Primidone (1)
- Rasagiline (1)
- Reboxetine (1)
- Risedronate sodium (1)
- Ropinirole (1)
- Rosuvastatin (1)
- Rotigotine (1)
- Selegiline (2)
- Sertraline (1)
- Simvastatin (1)
- Sodium valproate (1)
- Tacrolimus (1)
- Tiotropium (1)
- Tolcapone (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trimipramine (1)
- Venlafaxine (1)
- Vortioxetine (1)
- Warfarin (1)
Medicines planning (4)
- Patient Group Direction Planning (4)
Publications (3)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (20)
- Cardiovascular system disorders (4)
- Diabetes (2)
- Endocrine system disorders (1)
- Infection and infectious diseases (1)
- Learning disabilities (1)
- Mental health and illness (4)
- Neurological disorders (4)
- Renal and urologic disorders (1)
- Reproductive health (2)
- Travel Medicine (1)
- Vaccinating (2)
Training and Development (13)

How should dentists prescribe, store, order and dispose of controlled drugs?

6 June 2016This updated Q&A aims to explain controlled drug legislation relevant to primary care dental practice. Includes prescribing for NHS and private patients, ordering/requisitioning, storage and…

SPS National Patient Group Direction (PGD) exemplar templates

20 June 2019The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

Using Standardised Strengths of Unlicensed Liquid Medicines in Children

10 October 2019A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)

When and how can dentists supply medicines?

28 November 2019This updated Medicines Q&A aims to explain the legal status of medicines in the UK and when and how they may be supplied by dentists…

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Patient Group Direction use in Primary Care Networks

8 January 2020Guidance on the legislation and governance required when considering the use of PGDs across a PCN

Bank and agency staff and Patient Group Directions

25 February 2020The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.

What is the clinical significance of potential drug interactions with local anaesthetic preparations used in primary care dentistry?

30 July 2020This updated Medicines Q&A explores the clinical significance of potential interactions between dental local anaesthetic preparations and other medicines as listed in the BNF and…

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Direction (PGDs) for in End of Life Care

SPS - Specialist Pharmacy Service

NHS